Reset
Showing 18 of 18 academic articles

Correlation between sarcopenia and changes in oligodendrocyte lineage cells in the brains of Alzheimer's disease model mice

Lin-lin Yao, Xiao-ting Ma, Fang-bo Li, Lin-yi Zheng et al. • Experimental Gerontology (2026)

Background: Alzheimer's disease (AD) is a neurodegenerative disorder primarily characterized by cognitive dysfunction. The discovery and identification of non-cognitive symptoms in the preclinical stage hold promise for early diagnosis and ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.exger.2026.113057

Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers

Meng Zhang, Ping He, Zhigang Bian • Frontiers in Molecular Neuroscience (2021)

Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are progressive and ultimately fatal. NDD onset is influenced by several fa...

DOAJ Open Access (DOAJ) DOI: 10.3389/fnmol.2021.685143

Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease

Erden Eren, Jeannie-Marie Leoutsakos, Juan Troncoso, Constantine G. Lyketsos et al. • Cells (2022)

The hallmarks of Alzheimer’s disease (AD) pathology are senile plaques containing amyloid-beta (Aβ) and neurofibrillary tangles containing hyperphosphorylated tau. Additional pathologies often co-exist, whereas multiple pathogenic mechanism...

DOAJ Open Access (DOAJ) DOI: 10.3390/cells11030436

Association of inflammation and cognition in the elderly: A systematic review and meta-analysis

Sofia Leonardo, Felipe Fregni • Frontiers in Aging Neuroscience (2023)

BackgroundThe development of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) may be associated with an inflammatory process. Inflammatory cytokines may be a surrogate for systemic inflammation leading to worsening neurological ...

DOAJ Open Access (DOAJ) DOI: 10.3389/fnagi.2023.1069439

Effect of probiotics on cognitive function and cardiovascular risk factors in mild cognitive impairment and Alzheimer’s disease: an umbrella meta-analysis

Bin Xiao, Lina Fu, Zhe Yang, Guran Yu • Journal of Health, Population and Nutrition (2025)

Abstract Background This umbrella meta-analysis evaluates the effects of probiotics on cognitive function and metabolic health in Alzheimer’s disease (AD) and mild cognitive impairment (MCI) by synthesizing findings from meta-analyses of ra...

DOAJ Open Access (DOAJ) DOI: 10.1186/s41043-025-00816-3

Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts

Camila Fabiani, Camila Fabiani, Silvia S. Antollini, Silvia S. Antollini • Frontiers in Cellular Neuroscience (2019)

Biological membranes show lateral and transverse asymmetric lipid distribution. Cholesterol (Chol) localizes in both hemilayers, but in the external one it is mostly condensed in lipid-ordered microdomains (raft domains), together with satu...

DOAJ Open Access (DOAJ) DOI: 10.3389/fncel.2019.00309

The features analysis of hemoglobin expression on visual information transmission pathway in early stage of Alzheimer’s disease

Xuehui Li, Pan Tang, Xinping Pang, Xianghu Song et al. • Scientific Reports (2024)

Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized primarily by cognitive impairment. The motivation of this paper is to explore the impact of the visual information transmission pathway (V–H pathway) on AD, and...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-024-64099-0

Serum amyloid beta 42 levels correlated with metabolic syndrome and its components

Kecheng Li, Kecheng Li, Xiaoli Zhou, Xiaoli Zhou et al. • Frontiers in Endocrinology (2024)

IntroductionBeta-amyloid accumulation in the brain appears to be a key initiating event in Alzheimer’s disease (AD), and factors associated with increased deposition of beta-amyloid are of great interest. Enhanced deposition of amyloid-β pe...

DOAJ Open Access (DOAJ) DOI: 10.3389/fendo.2024.1278477

Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau

Lauren E. McCollum, Sandhitsu R. Das, Long Xie, Robin de Flores et al. • NeuroImage: Clinical (2021)

Mild cognitive impairment (MCI) can be an early manifestation of Alzheimer’s disease (AD) pathology, other pathologic entities [e.g., cerebrovascular disease, Lewy body disease, LATE (limbic-predominant age-related TDP-43 encephalopathy)], ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.nicl.2021.102717

The Effect of APOE ɛ4 on the Functional Connectivity in Frontoparietal Network in Hypertensive Patients

Dandan Wang, Chang Xu, Wenxiao Wang, Hui Lu et al. • Brain Sciences (2022)

Allele 4 of the apolipoprotein E gene (APOE ε4) and hypertension are considered risk factors for Alzheimer’s Disease (AD). The detection of differences in cognitive function and brain networks between hypertensive patients who are APOE ε4 c...

DOAJ Open Access (DOAJ) DOI: 10.3390/brainsci12050515

Epidemiology and risk factors of dementia

Wiesje M. van der Flier • Journal of Neurology Neurosurgery & Psychiatry (2005)

ementia refers to a syndrome that is characterised by progressive deterioration of cognitive functions.Neuropsychiatric symptoms, such as apathy, agitation, and depression, are also common.With increasing loss of function, a patient is grad...

OPENALEX Open Access DOI: https://doi.org/10.1136/jnnp.2005.082867 PMC: 1765715

Challenges in community-based recruitment of Alzheimer's disease cases: Experience of the monitoring drug efficacy through multi-omics research initiative in Alzheimer's disease (MEMORI-AD) study

Fresthel Monica M Climacosa, Eric David B Ornos, Erwin Rommel S Diwa, Mary Gale R Guantia et al. • Journal of Alzheimer's Disease Reports (2026)

Background The Monitoring drug Efficacy through Multi-Omics Research Initiative in Alzheimer's Disease (MEMORI-AD) study aims to characterize drug response to donepezil and memantine in a Filipino cohort with late-onset Alzheimer's disease ...

DOAJ Open Access (DOAJ) DOI: 10.1177/25424823261431318

Natural language processing in Alzheimer's disease research: Systematic review of methods, data, and efficacy

Arezo Shakeri, Mina Farmanbar • Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2025)

Abstract INTRODUCTION Alzheimer's disease (AD) prevalence is increasing, with no current cure. Natural language processing (NLP) offers the potential for non‐invasive diagnostics, social burden assessment, and research advancements in AD. M...

DOAJ Open Access (DOAJ) DOI: 10.1002/dad2.70082

Analysis and Classification of Word Co-Occurrence Networks From Alzheimer’s Patients and Controls

Tristan Millington, Saturnino Luz • Frontiers in Computer Science (2021)

In this paper we construct word co-occurrence networks from transcript data of controls and patients with potential Alzheimer’s disease using the ADReSS challenge dataset of spontaneous speech. We examine measures of the structure of these ...

DOAJ Open Access (DOAJ) DOI: 10.3389/fcomp.2021.649508

Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer’s disease

Clara Muñoz-Castro, Ayush Noori, Colin G. Magdamo, Zhaozhi Li et al. • Journal of Neuroinflammation (2022)

Abstract Background Astrocytes and microglia react to Aβ plaques, neurofibrillary tangles, and neurodegeneration in the Alzheimer’s disease (AD) brain. Single-nuclei and single-cell RNA-seq have revealed multiple states or subpopulations of...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12974-022-02383-4

Precise diagnosis of Alzheimer’s disease based on sex-specific gray matter characteristics

Jiachen Chen, Jiachen Chen, Jiachen Chen, Kaiping Wang et al. • Frontiers in Neuroscience (2026)

IntroductionThere are notable sex differences in the gray matter of Alzheimer’s disease(AD) patients’ brains, but current evidence is insufficient to prove these differences aid diagnosis effectively.MethodsMultivariate analysis of variance...

DOAJ Open Access (DOAJ) DOI: 10.3389/fnins.2026.1755938

Binaural Beat Stimulation Enhances Cognitive Function in Alzheimer’s Disease via Temporal Lobe Activation: An sLORETA Study

Muhammad Danish Mujib, Nayab Mubashir, Ahmad Zahid Rao, Nisha Nasir et al. • Biomedicines (2026)

Background: The global prevalence of Alzheimer’s disease (AD) has reached 55.2 million. AD is characterized by progressive deterioration in cognition and working memory (WM), which are essential for attention, reasoning, and learning. These...

DOAJ Open Access (DOAJ) DOI: 10.3390/biomedicines14030540